ADC Therapeutics SA (ADCT)
NYSE: ADCT · IEX Real-Time Price · USD
3.450
+0.010 (0.29%)
Jul 22, 2024, 11:21 AM EDT - Market open
ADC Therapeutics Employees
As of December 31, 2023, ADC Therapeutics had 274 total employees, including 273 full-time and 1 part-time employees. The number of employees decreased by 43 or -13.56% compared to the previous year.
Employees
274
Change (1Y)
-43
Growth (1Y)
-13.56%
Revenue / Employee
$250,434
Profits / Employee
-$829,318
Market Cap
327.17M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 274 | -43 | -13.56% |
Dec 31, 2022 | 317 | 5 | 1.60% |
Dec 31, 2021 | 312 | 104 | 50.00% |
Dec 31, 2020 | 208 | - | - |
Related Stocks
Company Name | Employees |
---|---|
ModivCare | 21,200 |
Nevro | 1,215 |
Spok Holdings | 384 |
Kamada | 378 |
Nautilus Biotechnology | 167 |
AC Immune | 161 |
Foghorn Therapeutics | 116 |
Cabaletta Bio | 103 |
ADCT News
- 14 days ago - Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development - GlobeNewsWire
- 25 days ago - ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 6 weeks ago - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - GlobeNewsWire
- 7 weeks ago - ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 2 months ago - ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 2 months ago - ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire